News / Taiwan / cnyes
健喬 (4114-TW) August Revenue Surges 50% to Record High
Health Technology · Pharmaceuticals: Major · cnyes · 2026-09-09
4114
Taiwanese pharmaceutical firm健喬 (4114-TW) reported a 49.88% year-on-year revenue increase for August, driven by strong sales in oncology and cardiovascular drugs.
What Happened
Revenue Growth:健喬 (4114-TW) announced August revenue of NT$754 million, marking a 49.88% year-on-year increase and the second-highest monthly performance in company history. Cumulative revenue for the first eight months of the year reached NT$5.096 billion, representing a 25.5% growth compared to the same period last year.
Product Performance: The company's core product lines showed strong momentum, with oncology, cardiovascular, and women's health medications growing by 43%, 48%, and 23% respectively. Additionally, nasal sprays and long-acting hormone therapies saw significant gains as they expanded their presence in major medical centers across Taiwan.
Market Expansion: The firm continues to deepen its footprint in digestive and women's health, with new drugs for chronic constipation and uterine fibroids now available in numerous medical institutions. Internationally, the company has secured distribution partnerships in Vietnam, with product launches anticipated by 2029.
Regulatory Milestone: The company's hormone production facility successfully passed the Japanese PMDA pharmaceutical compliance inspection in August. This achievement paves the way for future market entry into Japan and strengthens the company's overall international expansion strategy.
Read original
More in Health Technology
Health Technology · yonhap_finance · 2026-09-08
Shinhan Securities lowered its target price for Alteogen to 520,000 KRW after a drug candidate in its Novartis licensing deal failed a Phase 3 trial.
196170
Health Technology · cnbc · 2026-09-08
Novartis shares dropped following a failed cardiovascular trial, weighing on the broader biotech sector, while Boeing reported a monthly decline in aircraft deliveries.
@CL.1, US10Y, .SPX, .IXIC, NVS, .DJI, AMGN, BA, NVS, LLY, XBI, @LCO26X, ABBV, GILD, NVDA, CHWY, SIG
Health Technology · economic_daily · 2026-09-08
Joyo Pharmaceutical announced a 50% year-over-year revenue increase for August, driven by strong sales in oncology, cardiovascular, and women's health products.
4114
Latest in Taiwan
Electronic Technology · economic_daily · 2026-09-09
Ahead of Apple's upcoming product launch, optical lens stocks surged, with GSEO hitting a record high as investors bet on the new foldable iPhone and iPhone 18 series.
3008, 3406, 3504, 6209, 6668
Technology Services · economic_daily · 2026-09-09
Taiwan's TDCC has completed a major upgrade to its core securities system, enhancing transaction processing capacity and operational efficiency to handle record-high market activity.
Process Industries · economic_daily · 2026-09-09
Everlight Chemical's August revenue surged 33.2% year-over-year, fueled by an 86% jump in its electronic chemicals segment, now the company's second-largest business unit.
1711
Electronic Technology · cnyes · 2026-09-09
Following the latest FactSet survey, analysts have revised their 2026 EPS estimates for WT Microelectronics (3036-TW) upward to NT$26.62 with a target price of NT$300.
3036